In the BioHarmony Drug Report Database

"Preview" Icon

Efavirenz

Sustiva, Stocrin (efavirenz) is a small molecule pharmaceutical. Efavirenz was first approved as Sustiva on 1998-09-17. It is used to treat acquired immunodeficiency syndrome and HIV infections in the USA. It has been approved in Europe to treat HIV infections. It is known to target cytochrome P450 3A4.

 

Trade Name

 

Stocrin, Sustiva
 

Common Name

 

efavirenz
 

ChEMBL ID

 

CHEMBL223228
 

Indication

 

acquired immunodeficiency syndrome, hiv infections
 

Drug Class

 

Antivirals: non-nucleoside reverse transcriptase inhibitors; benzoxazinone derivatives; Fc fusion protein

Image (chem structure or protein)

Efavirenz structure rendering